FAQ: What cancers can be treated with CAR T-cell therapy?

CAR T-cell therapy has shown significant success in treating certain types of blood cancers. Currently, it is primarily approved and used to treat specific subtypes of leukemia and lymphoma. CAR T-cell therapy has been effective in treating acute lymphoblastic leukemia (ALL), certain cases of acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia (ALL), and multiple myeloma (MM). Ongoing research aims to explore its potential in treating other types of cancer as well, extending its application to solid tumors and other malignancies.